- Documento2009.-Weighing Benefits and Risks the FDA's Review of Prasugrelcaricato datristan9454
- Documento2009.Prasugrel in Clinical Practice..caricato datristan9454
- Documento2009.-Prasugrel in Clinical Practicecaricato datristan9454
- Documento2009.- Weighing Benfits and Risk...caricato datristan9454
- Documento2009.- Prasugrel Stemi Subgroup Analysis.autor's Replycaricato datristan9454
- Documento2009.- Prasugrel Stemi Subgroup Analysiscaricato datristan9454
- Documento2009.- Effect of the Novel Thienopyridine Prasugrel....caricato datristan9454
- Documento2008.-The Use of the VerifyNow P2Y12 Point-Of-care Device to Monitorcaricato datristan9454
- Documento2008.Prasugrel...Acute Coronary Syndromescaricato datristan9454
- Documento2008.-Prasugrel Achieves Greater and Faster P2Y12..caricato datristan9454
- Documento2008.-Bleeding Risks With Pasugre.....caricato datristan9454
- Documento2008. Prasugrel.....Patients With Acute Coronary.caricato datristan9454
- Documento2008. Intensive Anti Platelet ... Prasugrelcaricato datristan9454
- Documento2007.-A Comparison of the Anti Platelet Effects of Prasugrel..caricato datristan9454
- Documento2009.- Stroke Prevention in Atrial Fibrillation....caricato datristan9454
- Documento2009.- Cutaneous Blodd Filled Vesicles on Idraparinuxcaricato datristan9454
- Documento2009.- Comparison of Idraparinux With Vitamin Kcaricato datristan9454
- Documento2007.-High Affinity Interaction Between a Synthetic, Highly Negatively Charged..caricato datristan9454
- Documento2007.-Agents to Control Bleeding Show Promisecaricato datristan9454
- Documento2005.-Reversal of a Potent Investigational Anticoagulant Idraparinux With Recombinant Factor VIIa.caricato datristan9454
- Documento2005.Reversal Investigational Anticoagulan Idraparinux...caricato datristan9454
- Documento2004.Oligosaccharides...caricato datristan9454
- Documento2003.Synthetic Pentasaccharides...caricato datristan9454
- DocumentoShort- And Long-Acting Synthetic Pent a Sac Char Idescaricato datristan9454
- Documento2009.- The Pharmacokinetics of Idraparinux, A Long-Acting Indirect Factor Xa Inhibitor Population Pharmacokinetic Analysis From Phase III Clinical Trials.caricato datristan9454
- Documento2006.-Thrombocytopenia Associated With the Use ...caricato datristan9454
- Documento2006.-Frequency and Management of Thrombocytopenia...caricato datristan9454
- Documento2006.-Abciximab Associated Thrombocytopenia...caricato datristan9454
- Documento2005.-Immune Thrombocytopenia Caused by Glycoprotein....caricato datristan9454
- Documento2004.-Repetitive Profound Thrombocytopenia After Treatment With Tirofiban a Case Report.caricato datristan9454
- Documento2009.-First Report of Tirofiban-Induced Anemia (Found in Combination With Severe Thrombocytopeniacaricato datristan9454
- Documento2002.-Acute Thrombocytopenia After Treatment With Tirofiban or Eptifibatide is a2002.caricato datristan9454
- Documento2006.-Thrombocytopenia Associated With the Use ...caricato datristan9454
- Documento2006.-Frequency and Management of Thrombocytopenia...caricato datristan9454
- Documento2006.-Abciximab Associated Thrombocytopenia...caricato datristan9454
- Documento2005.-Immune Thrombocytopenia Caused by Glycoprotein....caricato datristan9454
- Documento2004.-Repetitive Profound Thrombocytopenia After Treatment With Tirofiban a Case Report.caricato datristan9454
- Documento2002.-Acute Thrombocytopenia After Treatment With Tirofiban or Eptifibatide is a2002.caricato datristan9454
- Documento2009.-First Report of Tirofiban-Induced Anemia (Found in Combination With Severe Thrombocytopeniacaricato datristan9454
- Documento1.-BISTRO Icaricato datristan9454
- Documento1.-BISTRO Icaricato datristan9454